The Technical Analyst
Guided Therapeutics, Inc. [GTHP]
Exchange: PNK Industry: Medical Devices
Guided Therapeutics, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
14.81% $0.100
America/New_York / 3 mai 2024 @ 12:21
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 5.56 mill |
| EPS: | -0.0700 |
| P/E: | -1.430 |
| Earnings Date: | May 13, 2024 |
| SharesOutstanding: | 55.61 mill |
| Avg Daily Volume: | 0.0232 mill |
| RATING 2024-05-03 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | |||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.430 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -1.430 | industry: PE -6.92 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0910 - 0.109 ( +/- 9.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-05 | Imhoff John E | Buy | 48 638 | Common Stock |
| 2024-03-26 | Imhoff John E | Buy | 4 420 | Common Stock |
| 2024-03-26 | Blumberg Richard P. | Buy | 38 893 | Common stock |
| 2024-03-26 | Blumberg Richard P. | Buy | 114 912 | Common stock |
| 2024-03-01 | Blumberg Richard P. | Buy | 400 000 | Common stock |
| INSIDER POWER |
|---|
| 45.15 |
| Last 99 transactions |
| Buy: 25 720 141 | Sell: 49 883 308 |
Forecast:
14:01 - $0.103
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.100 (14.81% ) |
| Volume | 0.0271 mill |
| Avg. Vol. | 0.0232 mill |
| % of Avg. Vol | 116.92 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For GTHP
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
GTHP
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Latest Press Releases
2015-11-06 09:05:00 - Press Release
Guided Therapeutics Schedules Conference Call To Discuss Third
Quarter 2015 Financial Results
Norcross, ga.--(business wire)--guided therapeutics, inc. (otcqb: gthp), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will report its 2015 third quarter financial results following the market close on thursday, november 12, 2015. the company has scheduled a conference call for friday, november 13, 2015 at 11:00 a.m. eastern time (et) to review the results. conference call information: dial in number for u.s. & canadian callers: 877-269-7756 dial in number for international callers (outside of the u.s. & canada): 201-689-7817 participating on the call will be guided therapeutics chief executive officer gene cartwright and controller charles rufai, who will discuss operational and financial highlights for the third quarter of 2015...
2015-08-04 14:02:00 - Press Release
Guided Therapeutics Schedules Conference Call To Discuss Second
Quarter 2015 Financial Results
Norcross, ga.--(business wire)--guided therapeutics, inc. (otcqb: gthp), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will report its 2015 second quarter financial results following the market close on wednesday, august 12, 2015. the company has scheduled a conference call for thursday, august 13, 2015 at 11:00 a.m. eastern time (et) to review the results. conference call information: date: thursday, august 13, 2015 time: 11:00 a.m. eastern time (et) dial in number for u.s. & canadian callers: 866-405-1201 dial in number for international callers (outside of the u.s. & canada): 201-689-8042 participating on the call will be guided therapeutics chief executive officer gene cartwright and controller charles rufai, who will discuss operational and financial highlights for the second quarter of 2015...
2015-05-19 16:05:00 - Press Release
Fda Completes Review Of Guided Therapeutics’ Luviva®
Advanced Cervical Scan Pma Application
Norcross, ga.--(business wire)--guided therapeutics, inc. (otcbb: gthp) (otcqb: gthp) today announced that it has received notification from the u.s. food and drug administration (fda) regarding the pre-market approval (pma) application for the luviva® advanced cervical scan. in its most recent communication, fda advised the company that its pma amendment, filed in july 2014, was not approvable in its current form. while the agency advised the company that more patient data would likely be necessary to amend the current application, the agency also stated its willingness to consider alternative approaches to move the product to approvable form. fda and the company intend to meet to discuss the plan for submission of an updated amendment and ultimately reach agreement on steps forward for a path to approval to resolve any remaining data analysis issues...
2015-04-29 08:05:00 - Press Release
Guided Therapeutics To Report First Quarter 2015 Results And Hold
Conference Call; Provide Update On Luviva Fda Timing
Norcross, ga.--(business wire)--guided therapeutics, inc. (otcbb: gthp) (otcqb: gthp), developer of a point-of-care and painless testing platform that uses biophotonics for the early detection of disease that leads to cervical cancer, today announced that it is scheduled to report financial results for its first quarter ended march 31, 2015 and provide an update on business activity on wednesday, may 13, 2015, after the market closes. guided therapeutics will hold a conference call at 11:00 a.m. edt on thursday, may 14, 2015, to discuss its financial results and corporate developments. interested parties are invited to listen to the call live over the internet at http://www.guidedinc.com/investors/...
2015-02-25 08:00:00 - Press Release
Guided Therapeutics To Report Fourth Quarter 2014 Results And Hold
Conference Call; Provide Update On Business Activity
Norcross, ga.--(business wire)--guided therapeutics, inc. (otcbb: gthp) (otcqb: gthp), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it is scheduled to report financial results for its fourth quarter and year ended december 31, 2014 and provide an update on business activity on wednesday, march 25, 2015, after the market closes. guided therapeutics will hold a conference call at 11:00 a.m. est thursday, march 26, 2015, to discuss its financial results and corporate developments. interested parties are invited to listen to the call live over the internet at http://www.guidedinc.com/investors/. the live call is also available by dialing (888) 455-2263 or for international callers (719) 325-2435 and referencing conference id 5351293...